|
Jul 29
|
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
|
|
May 6
|
Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?
|
|
May 4
|
Earnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
|
|
May 3
|
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Pulmonx First Quarter 2024 Earnings: Beats Expectations
|
|
May 2
|
Q1 2024 Pulmonx Corp Earnings Call
|
|
May 2
|
Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ...
|
|
May 1
|
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 1
|
Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses
|
|
May 1
|
Pulmonx Reports First Quarter 2024 Financial Results
|
|
Apr 10
|
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
|
|
Apr 2
|
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
|
|
Mar 15
|
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 1
|
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp
|
|
Feb 26
|
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
|
|
Feb 24
|
US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results
|
|
Feb 7
|
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
|
|
Dec 23
|
Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)
|
|
Dec 11
|
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors
|
|
Apr 25
|
Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference
|